Skip to search formSkip to main contentSkip to account menu

arformoterol

Known as: (-)-Formoterol, (R,R)-formoterol, Formoterol, ((R*,R*)-(+-))-isomer 
A long-acting beta-2 adrenergic agonist and isomer of formoterol with bronchodilator activity. Arformoterol selectively binds to and activates beta-2… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Introduction: The global initiative for chronic obstructive lung disease guidelines recommend maintenance therapy using long… 
2014
2014
Long-acting β-agonists (LABAs) are the standard of care for chronic obstructive pulmonary disease (COPD) patients with advanced… 
2013
2013
Enantiomers are one of several possible molecular configurations present in a drug that has at least 1 chiral center. A drug… 
Review
2012
Review
2012
There has been a real interest recently in developing once-daily β2-adrenoceptor agonists (ultra-long-acting β2-adrenoceptor… 
Review
2012
Review
2012
Chronic obstructive pulmonary disease (COPD) is the collective term for a lower respiratory tract condition that includes chronic… 
2010
2010
BACKGROUND Walking is a familiar daily activity that is generally limited by breathlessness, whereas cycling is an uncommon… 
2008
2008
The commercially available long acting anti-asthmatic drug, formoterol exists as a racemate of four enantiomers ((R,R)-, (R,S… 
2007
2007
Bronchodilators play an important role in the management of stable chronic obstructive pulmonary disease (COPD). Although… 
2003
2003
AIM To compare the bronchodilating and antiinflammatory effects of oral racemic formoterol (rac-FMT) and (R,R)-formoterol (R,R…